Judith Sluimer

Professor

Prof. Dr. Judith Sluimer defended her PhD thesis at Maastricht University in 2008, under supervision of Prof. Mat Daemen. She established the first proof of hypoxia in human and murine atherosclerosis and investigated the hypoxia-dependent formation and leaky phenotype of atherosclerotic plaque angiogenesis. After her PhD defense, she joined the lab of Prof. Ira Tabas (Columbia University, NYC, USA) in 2008 as a post-doctoral fellow to further her expertise in macrophage apoptosis, efferocytosis and autophagy (funded by the Netherlands Scientific Organisation (NWO, Rubicon), the international atherosclerosis society (IAS), and Maastricht University). Since 2010, Judith has established an independent research line to investigate pharmaceutical and genetic strategies to improve plaque oxygen levels and their impact on atherogenesis (NWO Veni). In 2013, CARIM consolidated her tenure track. 

Judith’s team in the Department of Pathology of Maastricht UMC+ currently works on the overarching goal and vision is to revert vascular ageing, atherosclerotic plaque destabilisation and ensuing clinical events by elucidating the role of inflammatory and fibrotic cellular players.

She studied cellular oxygen metabolism and autophagy as network member of the highly competitive Leducq grant scheme for transatlantic networks of excellence, and as 2016 recipient of the Dr. Dekker senior postdoc fellowship from the Dutch Heart Foundation. Her group benefits from interdisciplinary expertise through honorary scientist positions at RWTH Aachen and University of Edinburgh. These interactions have led to single cell sequencing data supporting heterogeneity of mesenchymal cells in healthy and diseased vasculature (NWO VIDI, ERA-CVD, Marie Curie fellowship, Humboldt fellowship). In addition to research and teaching, she has been mentor of BSc students in Medicine and Biomedical Sciences since 2011. Judith was local organizer of the ESM-EVBO conference (430 delegates) in Maastricht in 2019. She is associate editor for several journals, treasurer of the European Vascular Biology Organization (2019-2025), Member of the Basic Science council European society for cardiology (ESC), board member of the CARIM division Blood, and she chairs CARIM’s Grants & Incentives team, and the faculty-wide committee that advises the dean on promotions to assistant and associate professorships (2020-2026).

Department of Pathology
P. Debeyelaan 25, 6229 HX Maastricht
PO Box 616, 6200 MD Maastricht

  • 2024
    • Cao, J., Martin-Lorenzo, M., van Kuijk, K., Wieland, E., Gijbels, M. J., Claes, B. S. R., Heredero, A., Aldamiz-Echevarria, G., Heeren, R. M. A., Goossens, P., Sluimer, J., Balluff, B., & Alvarez-Llamas, G. (2024). Spatial Metabolomics Identifies LPC(18:0) and LPA(18:1): in Advanced Atheroma With Translation to Plasma for Cardiovascular Risk Estimation. Arteriosclerosis Thrombosis and Vascular Biology, 44(3), 741-754. https://doi.org/10.1161/ATVBAHA.123.320278
    • Lu, C., Donners, M. M. P. C., de Baaij, J. B. J., Jin, H., Otten, J. J. T., Manca, M., van Zonneveld, A. J., Jukema, J. W., Kraaijeveld, A., Kuiper, J., Pasterkamp, G., Mees, B., Sluimer, J. C., Cavill, R., Karel, J. M. H., Goossens, P., & Biessen, E. A. L. (2024). Identification of a gene network driving the attenuated response to lipopolysaccharide of monocytes from hypertensive coronary artery disease patients. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1286382
    • Sluiter, T. J., Tillie, R. J. H. A., de Jong, A., de Bruijn, J. B. G., Peters, H. A. B., van de Leijgraaf, R., Halawani, R., Westmaas, M., Starink, L. I. W., Quax, P. H. A., Sluimer, J. C., & de Vries, M. R. (2024). Myeloid PHD2 Conditional Knockout Improves Intraplaque Angiogenesis and Vascular Remodeling in a Murine Model of Venous Bypass Grafting. Journal of the American Heart Association, 13(3), 033109. Article e033109. https://doi.org/10.1161/JAHA.123.033109
    • Lin, A., Brittan, M., Baker, A. H., Dimmeler, S., Fisher, E. A., Sluimer, J. C., & Misra, A. (2024). Clonal Expansion in Cardiovascular Pathology. JACC: Basic to Translational Science, 9(1), 120-144. https://doi.org/10.1016/j.jacbts.2023.04.008
  • 2023
    • Sarad, K., Stefanska, M., Kraszewska, I., Szade, K., Sluimer, J. C., Blyszczuk, P., Dulak, J., & Jazwa-Kusior, A. (2023). Single-cell transcriptomics reveals subtype-specific molecular profiles in Nrf2-deficient macrophages from murine atherosclerotic aortas. Frontiers in Immunology, 14, Article 1249379. https://doi.org/10.3389/fimmu.2023.1249379
    • Maas, S., Jin, H., Lu, C., Nagenborg, J., Manca, M., Karel, J., Cavill, R., Sikkink, C., Yu, B., Nadeau, S., Dos Santos, J., Gijbels, M., Mees, B., Smirnov, E., Sluimer, J., Martins, G., Van der Vorst, E., & Biessen, E. (2023). Identification Of A Prdm1-Regulated T-Cell Network Which Controls T-Cell Driven Plaque Inflammation In Human And Mouse Atherosclerosis. Atherosclerosis, 379(S1), S11-S11. https://doi.org/10.1016/j.atherosclerosis.2023.06.914
    • van Kuijk, K., McCracken, I. R., Tillie, R. J. H. A., Asselberghs, S. E. J., Kheder, D. A., Muitjens, S., Jin, H., Taylor, R. S., Schreur, R. W., Kuppe, C., Dobie, R., Ramachandran, P., Gijbels, M. J., Temmerman, L., Kirkwoord, P. M., Luyten, J., Li, Y. M., Noels, H., Goossens, P., ... Sluimer, J. C. (2023). Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol. Cardiovascular Research, 119(7), 1509-1523. https://doi.org/10.1093/cvr/cvad016
    • Ruder, A. V., Temmerman, L., van Dommelen, J. M. A., Nagenborg, J., Lu, C., Sluimer, J. C., Goossens, P., & Biessen, E. A. L. (2023). Culture density influences the functional phenotype of human macrophages. Frontiers in Immunology, 14(1), Article 1078591. https://doi.org/10.3389/fimmu.2023.1078591
  • 2022
    • Evans, P. C., Davidson, S. M., Wojta, J., Bäck, M., Bollini, S., Brittan, M., Catapano, A. L., Chaudhry, B., Cluitmans, M., Gnecchi, M., Guzik, T. J., Hoefer, I., Madonna, R., Monteiro, J. P., Morawietz, H., Osto, E., Padró, T., Sluimer, J. C., Tocchetti, C. G., ... Weber, C. (2022). From novel discovery tools and biomarkers to precision medicine-basic cardiovascular science highlights of 2021/22. Cardiovascular Research, 118(13), 2754-2767. https://doi.org/10.1093/cvr/cvac114
    • Madrigal-Matute, J., Cuervo, A. M., & Sluimer, J. C. (2022). CHAPERONE-MEDIATED AUTOPHAGY PROTECTS AGAINST ATHEROSCLEROSIS. Autophagy, 18(10), 2505-2507. https://doi.org/10.1080/15548627.2022.2096397
    • Maas, S. L., Jin, H., Lu, C., Nagenborg, J., Karel, J. M. H., Cavill, R., Sikkink, C. J. J. M., Nadeau, S., Gijbels, M., Mees, B. M. E., Smirnov, E., Sluimer, J. C., Martins, G. A., Van der Vorst, E. P. C., & Biessen, E. A. L. (2022). Identification of a PRDM1-regulated T cell network to regulate T cell driving plaque inflammation in human and mouse atherosclerosis. European Heart Journal, 43, 3049-3049. https://doi.org/10.1093/eurheartj/ehac544.3049
    • Jin, H., Maas, S. L., Lu, C., Nagenborg, J., Manca, M., Karel, J. M. H., Cavill, R., Waring, O., Sikkink, C. J. J. M., Mees, B. M. E., Daemen, M. J. A. P., Smirnov, E., Sluimer, J., Van der Vorst, E., & Biessen, E. A. L. (2022). Identification Of Cd8+T Cell Prdm1 In High-Risk Human Plaques And Its Regulatory Role In Murine Lesion Development. Atherosclerosis, 355, E9-E9.
    • Maas, S. L., Jin, H., Lu, C., Nagenborg, J., Manca, M., Karel, J. M. H., Cavill, R., Waring, O., Sikkink, C. J. J. M., Mees, B. M. E., Daemen, M. J. A. P., Smirnov, E., Sluimer, J., van der Vorst, E. P. C., & Biessen, E. A. L. (2022). Identification of CD8+T cell PRDM1 in high-risk human plaques and its regulatory role in murine lesion development. Cardiovascular Research, 118(SUPPL 1). https://doi.org/10.1093/cvr/cvac066.186
    • Sluimer, J. C. (2022). RAC-king up Efferocytosis in Atherosclerotic Plaques With Aldehyde Dehydrogenase 2 Deficiency. Arteriosclerosis Thrombosis and Vascular Biology, 42(6), 717-718. https://doi.org/10.1161/ATVBAHA.122.317690
    • Madrigal-Matute, J., de Bruijn, J., van Kuijk, K., Riascos-Bernal, D. F., Diaz, A., Tasset, I., Martín-Segura, A., Gijbels, M. J. J., Sander, B., Kaushik, S., Biessen, E. A. L., Tiano, S., Bourdenx, M., Krause, G. J., McCracken, I., Baker, A. H., Jin, H., Sibinga, N. E. S., Bravo-Cordero, J. J., ... Cuervo, A. M. (2022). Protective role of chaperone-mediated autophagy against atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America, 119(14), Article 2121133119. https://doi.org/10.1073/pnas.2121133119
    • van Kuijk, K., Demandt, J. A. F., Perales-Patón, J., Theelen, T. L., Kuppe, C., Marsch, E., de Bruijn, J., Jin, H., Gijbels, M. J., Matic, L., Mees, B. M. E., Reutelingsperger, C. P. M., Hedin, U., Biessen, E. A. L., Carmeliet, P., Baker, A. H., Kramann, R. K., Schurgers, L. J., Saez-Rodriguez, J., & Sluimer, J. C. (2022). Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signalling. Cardiovascular Research, 118(5), 1232-1246. https://doi.org/10.1093/cvr/cvab152
    • Segers, F. M. E., Ruder, A. V., Westra, M. M., Lammers, T., Dadfar, S. M., Roemhild, K., Lam, T. S., Eline Kooi, M., Cleutjens, K. B. J. M., Verheyen, F. K., Schurink, G. W. H., Haenen, G. R., van Berkel, T. J. C., Bot, I., Halvorsen, B., Sluimer, J. C., & Biessen, E. A. L. (2022). Magnetic resonance imaging contrast-enhancement with superparamagnetic iron oxide nanoparticles amplifies macrophage foam cell apoptosis in human and murine atherosclerosis. Cardiovascular Research, 118, 3346-3359. https://doi.org/10.1093/cvr/cvac032
  • 2021
    • Jin, H., Mees, B., Biessen, E. A., & Sluimer, J. C. (2021). Transcriptional Sex Dimorphism in Human Atherosclerosis Relates to Plaque Type. Circulation Research, 129(12), 1175-1177. https://doi.org/10.1161/circresaha.121.320099
    • Posma, J. J. N., & Sluimer, J. C. (2021). Pleiotropic, Cellular Effects of Rivaroxaban on Autophagy Explain Atheroprotective Effects. JACC: Basic to Translational Science, 6(12), 981-983. https://doi.org/10.1016/j.jacbts.2021.10.015
    • Merlin, J., Ivanov, S., Dumont, A., Sergushichev, A., Gall, J., Stunault, M., Ayrault, M., Vaillant, N., Castiglione, A., Swain, A., Orange, F., Gallerand, A., Berton, T., Martin, J.-C., Carobbio, S., Masson, J., Gaisler-Salomon, I., Maechler, P., Rayport, S., ... Yvan-Charvet, L. (2021). Non-canonical glutamine transamination sustains efferocytosis by coupling redox buffering to oxidative phosphorylation. Nature Metabolism, 3(10), 1313-1326. https://doi.org/10.1038/s42255-021-00471-y
    • Tillie, R. J. H. A., De Bruijn, J., Perales-Paton, J., Temmerman, L., Ghosheh, Y., Van Kuijk, K., Gijbels, M. J., Carmeliet, P., Ley, K., Saez-Rodriguez, J., & Sluimer, J. C. (2021). Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis. Frontiers in Cell and Developmental Biology, 9, Article 695684. https://doi.org/10.3389/fcell.2021.695684
    • Tillie, R. J. H. A., Theelen, T. L., van Kuijk, K., Temmerman, L., de Bruijn, J., Gijbels, M., Betsholtz, C., Biessen, E. A. L., & Sluimer, J. C. (2021). A Switch from Cell-Associated to Soluble PDGF-B Protects against Atherosclerosis, despite Driving Extramedullary Hematopoiesis. Cells, 10(7), Article 1746. https://doi.org/10.3390/cells10071746
    • Jin, H., Goossens, P., Juhasz, P., Eijgelaar, W.-J., Manca, M., Karel, J., Smirnov, E., Sikkink, C. J. J. M., Mees, B., Waring, O., van Kuijk, K., Fazzi, G., Gijbels, M., Kutmon, M., Evelo, C., Hedin, U., Daemen, M. J., Sluimer, J., Matic, L. P., & Biessen, E. (2021). Integrative multiomics analysis of human atherosclerosis reveals a serum response factor-driven network associated with intraplaque hemorrhage. Clinical and Translational Medicine, 11(6), Article e458. https://doi.org/10.1002/ctm2.458
    • Sluimer, J. C., & Biessen, E. A. L. (2021). Arterial lymphangiogenesis ReSPONDINg 2 a new cue: the R-spondin2/LRG4 axis limits VEGFR3-mediated lymphangiogenesis and reverse cholesterol transport. Cardiovascular Research, 117(6), 1417-1419. https://doi.org/10.1093/cvr/cvab050
    • Demandt, J. A. F., van Kuijk, K., Theelen, T. L., Marsch, E., Heffron, S. P., Fisher, E. A., Carmeliet, P., Biessen, E. A. L., & Sluimer, J. C. (2021). Whole-Body Prolyl Hydroxylase Domain (PHD) 3 Deficiency Increased Plasma Lipids and Hematocrit Without Impacting Plaque Size in Low-Density Lipoprotein Receptor Knockout Mice. Frontiers in Cell and Developmental Biology, 9, Article 664258. https://doi.org/10.3389/fcell.2021.664258
    • Vacante, F., Rodor, J., Lalwani, M. K., Mahmoud, A. D., Bennett, M., De Pace, A. L., Miller, E., Van Kuijk, K., de Bruijn, J., Gijbels, M., Williams, T. C., Clark, M. B., Scanlon, J. P., Doran, A. C., Montgomery, R., Newby, D. E., Giacca, M., O'Carroll, D., Hadoke, P. W. F., ... Baker, A. H. (2021). CARMN Loss Regulates Smooth Muscle Cells and Accelerates Atherosclerosis in Mice. Circulation Research, 128(9), 1258-1275. https://doi.org/10.1161/CIRCRESAHA.120.318688
    • Moonen, R. P. M., Coolen, B. E., Sluimer, J. C., Daemen, M. J. A. P., & Strijkers, G. J. (2021). Iron Oxide Nanoparticle Uptake in Mouse Brachiocephalic Artery Atherosclerotic Plaque Quantified by T-2-Mapping MRI. Pharmaceutics, 13(2), Article 279. https://doi.org/10.3390/pharmaceutics13020279
    • Demandt, J. A. F., Dubois, L. J., van Kuijk, K., Zat'ovicova, M., Jin, H., Parkkila, S., van der Laan, S. W., Jelenska, L., Mees, B. M. E., Reutelingsperger, C. P. M., Cleutjens, K. B. J. M., van der Kallen, C. J. H., Schalkwijk, C. G., van Greevenbroek, M. M. J., Biessen, E. A. L., Pasterkamp, G., Pastorekova, S., Stehouwer, C. D. A., & Sluimer, J. C. (2021). The hypoxia-sensor carbonic anhydrase IX affects macrophage metabolism, but is not a suitable biomarker for human cardiovascular disease. Scientific Reports, 11(1), Article 425. https://doi.org/10.1038/s41598-020-79978-5
    • Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Princely Abudu, Y., Acevedo-Arozena, A., Sluimer, J., Vooijs, M., Keulers, T., Rouschop, K., & Neumann, D. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy, 17(1), 1-382. https://doi.org/10.1080/15548627.2020.1797280
  • 2020
    • Baardman, J., Verberk, S. G. S., van der Velden, S., Gijbels, M. J. J., van Roomen, C. P. P. A., Sluimer, J. C., Broos, J. Y., Griffith, G. R., Prange, K. H. M., van Weeghel, M., Lakbir, S., Molenaar, D., Meinster, E., Neele, A. E., Kooij, G., de Vries, H. E., Lutgens, E., Wellen, K. E., de Winther, M. P. J., & Van den Bossche, J. (2020). Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques. Nature Communications, 11(1), Article 6296. https://doi.org/10.1038/s41467-020-20141-z
    • van Geffen, J. P., Swieringa, F., van Kuijk, K., Tullemans, B. M. E., Solari, F. A., Peng, B., Clemetson, K. J., Farndale, R. W., Dubois, L. J., Sickmann, A., Zahedi, R. P., Ahrends, R., Biessen, E. A. L., Sluimer, J. C., Heemskerk, J. W. M., & Kuijpers, M. J. E. (2020). Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome. Scientific Reports, 10(1), Article 21407. https://doi.org/10.1038/s41598-020-78522-9
    • Tillie, R. J. H. A., van Kuijk, K., & Sluimer, J. C. (2020). Fibroblasts in atherosclerosis: heterogeneous and plastic participants. Current Opinion in Lipidology, 31(5), 273-278. https://doi.org/10.1097/MOL.0000000000000700
    • Legein, B., Janssen, E. M., Theelen, T., Gijbels, M., Walraven, J., Klarquist, J. S., Hennies, C. M., Wouters, K., Seijkens, T., Wijnands, E., Sluimer, J., Lutgens, E., Zenke, M., Hildner, K., Biessen, E., & Temmerman, L. (2020). Author Correction: Ablation of CD8α+ dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice. Scientific Reports, 10(1), Article 8747. https://doi.org/10.1038/s41598-020-65653-2
    • Hung, J., Scanlon, J. P., Mahmoud, A. D., Rodor, J., Ballantyne, M., Fontaine, M. A. C., Temmerman, L., Kaczynski, J., Connor, K. L., Bhushan, R., Biessen, E. A. L., Newby, D. E., Sluimer, J. C., & Baker, A. H. (2020). Novel Plaque Enriched Long Noncoding RNA in Atherosclerotic Macrophage Regulation (PELATON). Arteriosclerosis Thrombosis and Vascular Biology, 40(3), 697-713. https://doi.org/10.1161/ATVBAHA.119.313430
    • Parma, L., Peters, H. A. B., Baganha, F., Sluimer, J. C., de Vries, M. R., & Quax, P. H. A. (2020). Prolonged Hyperoxygenation Treatment Improves Vein Graft Patency and Decreases Macrophage Content in Atherosclerotic Lesions in ApoE3*Leiden Mice. Cells, 9(2), Article 336. https://doi.org/10.3390/cells9020336
  • 2019
    • Beldman, T. J., Malinova, T. S., Desclos, E., Grootemaat, A. E., Misiak, A. L. S., van der Velden, S., van Roomen, C. P. A. A., Beckers, L., van Veen, H. A., Krawczyk, P. M., Hoebe, R. A., Sluimer, J. C., Neele, A. E., de Winther, M. P. J., van der Wel, N. N., Lutgens, E., Mulder, W. J. M., Huveneers, S., & Kluza, E. (2019). Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy. ACS Nano, 13(12), 13759-13774. https://doi.org/10.1021/acsnano.8b08875
    • Fontaine, M. A. C., Westra, M. M., Bot, I., Jin, H., Franssen, A. J. P. M., Bot, M., de Jager, S. C. A., Dzhagalov, I., He, Y.-W., van Vlijmen, B. J. M., Gijbels, M. J. J., Reutelingsperger, C. P., van Berkel, T. J. C., Sluimer, J. C., Temmerman, L., & Biessen, E. A. L. (2019). Low human and murine Mcl-1 expression leads to a pro-apoptotic plaque phenotype enriched in giant-cells. Scientific Reports, 9, Article 14547. https://doi.org/10.1038/s41598-019-51020-3
    • van Kuijk, K., Kuppe, C., Betsholtz, C., Vanlandewijck, M., Kramann, R., & Sluimer, J. C. (2019). Heterogeneity and plasticity in healthy and atherosclerotic vasculature explored by single-cell sequencing. Cardiovascular Research, 115(12), 1705-1715. https://doi.org/10.1093/cvr/cvz185
    • Mahmoud, A. D., Ballantyne, M. D., Miscianinov, V., Pinel, K., Hung, J., Scanlon, J. P., Iyinikkel, J., Kaczynski, J., Tavares, A. S., Bradshaw, A. C., Mills, N. L., Newby, D. E., Caporali, A., Gould, G. W., George, S. J., Ulitsky, I., Sluimer, J. C., Rodor, J., & Baker, A. H. (2019). The Human-Specific and Smooth Muscle Cell-Enriched LncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling. Circulation Research, 125(5), 535-551. https://doi.org/10.1161/CIRCRESAHA.119.314876
    • Jin, H., Goossens, P., Karel, J., Daemen, M., Sluimer, J., & Biessen, E. (2019). Integrative Multi-Omics Analysis Of Human Atherosclerosis Reveals An Intraplaque Bleeding Associated Network, Which Offers Better Prediction Of Disease Stage. Atherosclerosis, 287, e63-e63. Article EAS19-0625. https://doi.org/10.1016/j.atherosclerosis.2019.06.180
    • Van Kuijk, K., Theelen, T., Demandt, J., Marsch, E., Gijbels, M., Jin, H., Reutelingsperger, C., Cosemans, J., Schurgers, L., Carmeliet, P., Biessen, E., Daemen, M., & Sluimer, J. (2019). MYELOID PHD2 KNOCKDOWN DRIVES MACROPHAGE APOPTOSIS AND PARACRINE FIBROBLAST/SMOOTH MUSCLE CELL COLLAGEN SECRETION LEADING TO ATHEROSCLEROTIC PLAQUE FIBROSIS. Atherosclerosis, 287, E10-E10. https://doi.org/10.1016/j.atherosclerosis.2019.06.027
    • Sluimer, J. C., & Houben, A. J. H. M. (2019). Joint ESM-EVBO meetings: past, present, and future. Cardiovascular Research, 115(4), E46-E48. https://doi.org/10.1093/cvr/cvz041
    • Vacante, F., Denby, L., Sluimer, J. C., & Baker, A. H. (2019). The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease. Vascular Pharmacology, 112, 24-30. https://doi.org/10.1016/j.vph.2018.11.006
  • 2018
    • McCracken, I. R., Taylor, R. S., Henderson, N. C., Sluimer, J. C., & Baker, A. H. (2018). Unravelling atherosclerotic heterogeneity by single cell RNA sequencing. Current Opinion in Lipidology, 29(6), 488-489. https://doi.org/10.1097/MOL.0000000000000559
    • Hung, J., Miscianinov, V., Sluimer, J. C., Newby, D. E., & Baker, A. H. (2018). Targeting Non-coding RNA in Vascular Biology and Disease. Frontiers in physiology, 9, Article 1655. https://doi.org/10.3389/fphys.2018.01655
    • Caporali, A., Back, M., Daemen, M. J., Hoefer, I. E., Jones, E. A., Lutgens, E., Matter, C. M., Bochaton-Piallat, M.-L., Siekmann, A. F., Sluimer, J. C., Steffens, S., Tunon, J., Vindis, C., Wentzel, J. J., Yla-Herttuala, S., & Evans, P. C. (2018). Future directions for therapeutic strategies in post-ischaemic vascularization: a position paper from European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology. Cardiovascular Research, 114(11), 1411-1421. https://doi.org/10.1093/cvr/cvy184
    • Sedding, D. G., Boyle, E. C., Demandt, J. A. F., Sluimer, J. C., Dutzmann, J., Haverich, A., & Bauersachs, J. (2018). Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease. Frontiers in Immunology, 9, Article 706. https://doi.org/10.3389/fimmu.2018.00706